Transforming growth factor-β induced by live or ultraviolet-inactivated equid herpes virus type-1 mediates immunosuppression in the horse

Immunology

Volumn 90, Issue 4, 1997, Pages 586-591

  Charan, S ^a   Palmer, K ^a   Chester, P ^a   Mire Sluis, A R ^b   Meager, A ^b   Edington, N ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EQUINE HERPES VIRUS; HORSE; IMMUNIZATION; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; ULTRAVIOLET RADIATION; VIRUS INFECTION;

EID: 0030950422     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00202.x     Document Type: Article

References (33)

1. ALLEN G.P. & BRYANS J.T. (1986) Molecular epizootiology, pathogenesis and prophylaxis of equine herpesvirus-1 infections. Progr Vet Microbiol Immunol 2, 78.
2. BRYANS J.T. & GERBER H. (1978) Cellular immunity to equine rhinopneumonitis virus in pregnant mares. J Equine Med Surg Suppl. 1, 2, 115.
3. MUMFORD J.A., ROSSDALE P.D., JESSETT D.M., GANN S.J., OUSEY J. & COOK R.F. (1987) Serological and virological investigations of an equid herpesvirus I (EHV-1) abortion storm on a stud farm in 1985. J Reprod Fert Suppl. 35, 509.
4. ALLISON A.C. (1973) Interactions of T- and B-lymphocytes and macrophages in recovery from virus infections. Proc R Soc Med 66, 1151.
5. BURROWS R, GOODBRIDGE D. & DENYER M.S. (1984) Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a sub type-1 virus. Vet Rec 114, 369.
6. MUMFORD J.A. & BATES J. (1984) Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 2 virus. Vet Record 114, 375.
7. GUO P., GOEBEL S., DAVIS S. et al. (1989) Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp 13 and protection immunized animals. J Virol 63, 4189.
8. COOK R.F., O'NEILL T., STRACHAN E., SUNDQUIST B. & MUMFORD J.A. (1990) Protection against lethal equine herpes virus type 1 (subtype 1) infection in hamsters by immune stimulating complexes ( ISCOMs) containing the major viral glycoproteins. Vaccine 8, 491.
9. STOKES A., CORTEYN A.H., PULLEN L.A. et al. (1991) Studies on glycoprotein 13 (gp13) of equid herpesvirus 1 using affinity-purified gp13, glycoprotein-specific monoclonal antibodies and synthetic peptides in a hamster model. J Gen Virol 72, 923.
10. PATEL J.R. & EDINGTON N. (1983) The pathogenicity in mice of respiratory, abortion and paresis isolates of equine herpes virus-1 in foals. Arch Virol 74, 41.
11. CHESTER P.C., STEELE M., PUREWAL A.P. & EDINGTON N. (1997) Nucleotide sequence of equine cDNA encoding a homologue of Mx protein. DNA Sequence, in press.
12. MEAGER A. (1991) Assays for TGFB. J Immunol Meth 141, 1.
13. GONCALVES M., NICOLSON L. & ONIONS D.E. (1997) Gene Bank Access. X99547.
14. FLANDERS K.C., ROBERTS A.B., LING N., FLEURDELYS B.E. & SPORN M.B. (1988) Antibodies to peptide determinants in transforming growth factor B and their applications. Biochemistry 27, 739.
15. WADHWA M., BIRD G., TIMBER A., MIRE-SLUIS A. & THORPE R. (1991) Quantitative biological assay for individual cytokines. In Cytokines (ed. F.R. Blackwill) p. 309. IRL Press, Oxford.
16. O'HAGAN D.T., JEFFERY Y.H., ROBERTS M.J.J., McGEE J.P. & DAVIS S.S. (1991) Controlled release microparticles for vaccine development. Vaccine 9, 768.
17. EDINGTON N., BRIDGES C.G. & PATEL J.R. (1986) Endothelial cell infection and thrombosis in paralysis caused by Equid herpesvirus 1: equine stroke. Arch Virol 90, 111.
18. 1 on experimental autoimmune diseases in mice. Immunology 88, 2918.
19. THORBECKS G.J., SHAH R., LEU C.H., KURUVILLA A.P., HARDISON A.M. & PALLADINO M.A. (1992) Involvement of endogenous tumor necrosis factor a and transforming growth factor β during induction of collagen type II arthritis in mice. Immunology 89, 7375.
20. LOWRANCE J.H., O'SULLIVAN F.X., CAVER T.E., WAEGELL W. & GRESHAM H.D. (1994) Spontaneous elaboration of transforming growth factor β suppresses host defense against bacterial infection in autoimmune MRL/1pr mice. J Exp Med 180, 1693.
21. MICHELSON S., ALCAMI J., KIM S.J. et al. (1994) Human cytomegalovirus infection induces transcription and secretion of transforming growth factor β1. J Virol 68, 5730.
22. HEISE MT. & VIRGIN H.T. (1995) The T cell independent role of γ Interferon & TNFα in macrophage activation during murine cytomegalovirus and HSV infections. J Virol 69, 904.
23. DAVIGNON J.L., CASTANIE P., YORKE J.A., GAUTIER N., CLEMENT D. & DAVINCHE C. (1996) Anti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro. J Virol 70, 2162.
24. RINALDO C.R. JR. & TORPEY D.J. (1993) Cell-mediated immunity and immunosuppression in herpes simplex virus infection. Immunodeficiency 5, 33.
25. BAUER G., GOTSCHL M. & HOFLER P. (1991) Tumor promoting activity of Epstein-Barr virus-inducing factor transforming growth factor beta (EIF/TGF-β) is due to the induction or irreversible transformation. Int J Cancer 47, 881.
26. DUTTA S.K., MYRUP A. & BUMGARDNER M.K. (1980) Lymphocyte responses to virus and mitogen in ponies during experimental infection with equine herpesvirus I. Am J Vet Med 41, 2066.
27. HANNANT D., O'NEILL T., JESSETT D.M. & MUMFORD J.A. (1991) Evidence for non-specific immunosuppression during the development of immune responses to Equid Herpesvirus-1. Equine Immunol Suppl. 12, 41.
28. WOODROFFE S.B., GARNETT H.M. & DAVIS V.A. (1993) Interleukin 1 production and cell activation response to cytomegalovirus infection of vascular endothelial cells. Archiv Virol 133, 295.
29. GROTENDORST G.R., SMALE G. & PENCEV D. (1989) Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils. J Cell Physiol 140, 396.
30. TWARDZIK D.R., MIKOVITS J.A., TANCHALIS J.E., PURCHIO A.F., ELLINGSWORTH L. & RUSCETTI F.W. (1990) Gamma-interferon-induced activation of latent transforming growth factor-β by human monocytes. Ann N Y Acad Sci 593, 276.
31. EDINGTON N., BRIDGES C.G. & GRIFFITHS I. (1989) Equine interferons following exposure to Equid herpesvirus 1 or 4. J Interferon Res 9, 389.
32. BRIDGES C.G. & EDINGTON N. (1986) Innate immunity during Equid herpesvirus 1 (EHV 1) infection. Clin Exp Immunol 65, 172.
33. FONTANA A., FREI K., BODMER S. et al. (1989) TGFB inhibits the generation of cytotoxic T cells in virus-infected mice. J Immunol 143, 3230.